Sigma Healthcare Upgrades FY25 Earnings Guidance.

Sigma Healthcare Limited (ASX: SIG) has raised its full-year normalised EBIT guidance for FY25 to a range of AU$64 to AU$70 million, an increase from its previous estimate of AU$50 to AU$60 million provided in September 2024. This upgrade is attributed to improved operational performance, particularly the successful execution of its new Chemist Warehouse supply contract, which commenced on 1 July 2024. The company has demonstrated its capacity to efficiently manage increased volume growth, contributing to the upward revision of its financial outlook. 

However, Sigma's FY25 statutory NPAT is expected to be significantly impacted by non-recurring merger-related costs, including changes to existing performance rights approved at the company's Extraordinary General Meeting (EGM). These one-off expenses will affect the final reported earnings. Sigma plans to release its full-year audited results to the ASX by mid-March 2025, providing further clarity on its financial position and performance.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com